Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12621000587808
Ethics application status
Approved
Date submitted
1/03/2020
Date registered
18/05/2021
Date last updated
21/04/2022
Date data sharing statement initially provided
18/05/2021
Type of registration
Prospectively registered
Titles & IDs
Public title
Salt and water balance in children with appendicitis
Query!
Scientific title
Sodium and Water homeostasis in children admitted with acute appendicitis: an observational prospective fluid balance cohort study
Query!
Secondary ID [1]
300683
0
Nil known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Appendicitis
316492
0
Query!
Dehydration
316493
0
Query!
Condition category
Condition code
Surgery
314740
314740
0
0
Query!
Other surgery
Query!
Oral and Gastrointestinal
317172
317172
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Metabolic and Endocrine
317173
317173
0
0
Query!
Other metabolic disorders
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
False
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
This cohort study that will be conducted in normonatremic children admitted with acute appendicitis. On admission, all patients will receive an intravenous infusion of 50 mL/kg of Ringer’s acetate solution (131 mmol/L sodium, 4 mmol/L potassium, 2 mmol/L magnesium, 110 mmol/L chloride, 30 mmol/L acetate; Fresenius Kabi®) over four hours. This infusion will be followed by a maintenance fluid and electrolyte therapy phase consisting of a hypotonic 0.46% normal sodium chloride (80 mmol/L sodium, 20 mmol/L potassium, 100 mmol/L chloride; extempore solution) in 5% glucose solution until the start of the surgery. At the maintenance stage, infusion rate will be decreased to 80% of normal maintenance fluid therapy. The duration of the maintenance fluid phase will be approximately 12 hours. All participants will normally receive this treatment regardless of their involvement in this observational study. During surgery, fluids will be administered at anesthetist’s discretion. The total duartion of the observation for participants in this sudy will be until the end of surgery.
Query!
Intervention code [1]
317011
0
Not applicable
Query!
Comparator / control treatment
No control group
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
323088
0
The primary outcome of this study is to evaluate mean plasma-sodium assessed by indirect ion-selective electrode method. This will be assessed by means of analyzing plasma-sodium
Query!
Assessment method [1]
323088
0
Query!
Timepoint [1]
323088
0
Timepoint: directly after surgery.
Query!
Secondary outcome [1]
387341
0
The occurrence of hyponatremia (plasma-sodium <135 mmol/L). This will be assessed by means of determining plasma-sodium will be assessed by indirect ion-selective electrode method.
Query!
Assessment method [1]
387341
0
Query!
Timepoint [1]
387341
0
Timepoint: directly after surgery
Query!
Eligibility
Key inclusion criteria
1). Admitted for suspected appendicitis.
2). Informed consent obtained from parents and if applicable from the child.
Query!
Minimum age
10
Years
Query!
Query!
Maximum age
18
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1). Having received intravenous fluid therapy before the admission at our hospital
2). Plasma-sodium <135 mmol/L.
3). Documented diagnosis of renal, endocrine, or metabolic disease.
Query!
Study design
Purpose
Natural history
Query!
Duration
Longitudinal
Query!
Selection
Defined population
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Statistical analyses will be performed using IBM SPSS Statistics for Windows version 24 (IBM Corp, Armonk, NY). All continuous variables will be presented as medians and interquartile ranges (IQR), unless otherwise stated. Paired t-test will be carried out to compare individual differences between admission and at the end of surgery, Pearson correlation coefficient will be used to measure association between two variables, Fisher’s exact test will be used to compare dichotomous variables, and analysis of variance (ANOVA) followed by the post-hoc Bonferroni test, will be performed for multiple pair-wise comparisons, i.e., between admission, before induction and at the end of surgery. Two-tailed p values less than 0.05 will be considered statistically significant.
Query!
Recruitment
Recruitment status
Stopped early
Query!
Data analysis
Data collected is being analysed
Query!
Reason for early stopping/withdrawal
Other reasons/comments
Query!
Other reasons
With the onset of the pandemic, there was a reorganization of hospital and medical spaces and staff to prioritize COVID-19–infected patients. This had a negative impact on the enrollment of patients in the study. In addition, since the primary endpoint was to evaluate the mean changes in PNa from hospital admission to the end of surgery, we calculate the sample size based on our previously published data, which also included patients that became hyponatremic. According to our calculation, a sample size of about 25 participants was needed to detect clinically relevant changes in PNa. However, none of the enrolled participants who underwent surgery (n = 21) developed post-operative hyponatremia. In view of all these facts, the study was stopped earlier than planned.
Query!
Date of first participant enrolment
Anticipated
1/06/2021
Query!
Actual
19/05/2021
Query!
Date of last participant enrolment
Anticipated
1/12/2021
Query!
Actual
28/02/2022
Query!
Date of last data collection
Anticipated
31/01/2022
Query!
Actual
4/03/2022
Query!
Sample size
Target
25
Query!
Accrual to date
Query!
Final
21
Query!
Recruitment outside Australia
Country [1]
22407
0
Sweden
Query!
State/province [1]
22407
0
Stockholm
Query!
Funding & Sponsors
Funding source category [1]
305126
0
Hospital
Query!
Name [1]
305126
0
Södersjukhuset AB, Stockholm.
Query!
Address [1]
305126
0
Sjukhusbacken 10, 118 83 Stockholm.
Query!
Country [1]
305126
0
Sweden
Query!
Primary sponsor type
Individual
Query!
Name
Rafael Tomas Krmar
Query!
Address
Department of Physiology and Pharmacology (FyFa), Biomedicum, Solnavägen 9, SE-171 65 Solna, Sweden.
Query!
Country
Sweden
Query!
Secondary sponsor category [1]
305487
0
None
Query!
Name [1]
305487
0
Query!
Address [1]
305487
0
Query!
Country [1]
305487
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
305497
0
Swedish Ethical Review Authority
Query!
Ethics committee address [1]
305497
0
Box 2110 S-750 02 Uppsala Sweden
Query!
Ethics committee country [1]
305497
0
Sweden
Query!
Date submitted for ethics approval [1]
305497
0
01/07/2020
Query!
Approval date [1]
305497
0
05/10/2020
Query!
Ethics approval number [1]
305497
0
2020-03166
Query!
Summary
Brief summary
There is a prevalent view that in hospitalized patients with high circulating plasma vasopressin levels the administration of hypotonic fluid therapy is invariably associated with the occurrence of hyponatremia. Consequently, the prescription of hypotonic fluid therapy to hospitalized patients is discouraged. In a previous study, conducted in children admitted with acute appendicitis, we have observed that correction of hypovolemia with near-isotonic fluid solution followed by hypotonic maintenance intravenous fluid therapy was not consistently associated with post-operative hyponatremia, and that the degree of hyponatremia in patients that became hyponatremic was always mild (Lindestam U. et al. Ped. Res. 2019). We noted that in patients with high circulating vasopressin levels, the degree of post-operative water retention declined significantly, as patients became euvolemic. This apparent escape from the antidiuretic effects of vasopressin attracted our attention and therefore is the focus of the proposed investigation. Our assumption is that on admission most participants will have high circulating vasopressin levels. As a result of fluid therapy, we expect therefore a decrease of plasma-sodium at the end of surgery. The collection of new data has been planned based on an existing hypothesis, namely that we anticipate that some participants will show an escape from the antidiuretic effects of vasopressin. To shed light on this phenomenon, we will evaluate the changes in plasma-sodium from hospital admission to the end of surgery in acutely ill normonatremic children with appendicitis and relate them to key hormones involved in sodium and water homeostasis, to how much free water is being excreted or reabsorbed, and to surrogate markers of vasopressin-dependent trafficking of aquaporin-2 water channel.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
100566
0
Dr Rafael Tomas Krmar
Query!
Address
100566
0
Karolinska Institutet, Department of Physiology and Pharmacology (FyFa), Biomedicum
Solnavägen 9, SE-171 65 Solna
Sweden
Query!
Country
100566
0
Sweden
Query!
Phone
100566
0
+46 733200146
Query!
Fax
100566
0
Query!
Email
100566
0
[email protected]
Query!
Contact person for public queries
Name
100567
0
Rafael Tomas Krmar
Query!
Address
100567
0
Karolinska Institutet, Department of Physiology and Pharmacology (FyFa), Biomedicum
Solnavägen 9, SE-171 65 Solna
Sweden
Query!
Country
100567
0
Sweden
Query!
Phone
100567
0
+46 733200246
Query!
Fax
100567
0
Query!
Email
100567
0
[email protected]
Query!
Contact person for scientific queries
Name
100568
0
Rafael Tomas Krmar
Query!
Address
100568
0
Karolinska Institutet, Department of Physiology and Pharmacology (FyFa), Biomedicum
Solnavägen 9, SE-171 65 Solna
Sweden
Query!
Country
100568
0
Sweden
Query!
Phone
100568
0
+46 733200146
Query!
Fax
100568
0
Query!
Email
100568
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
Query!
What data in particular will be shared?
All the individual participant data collected during the study.
Query!
When will data be available (start and end dates)?
Immediately following publication, no end date determined.
Query!
Available to whom?
Case-by-case basis at the discretion of primary sponsor.
Query!
Available for what types of analyses?
Only to achieve the aims of the approved proposal.
Query!
How or where can data be obtained?
Access subject to approvals by principal investigator; Rafael Tomas Krmar, email:
[email protected]
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
7183
Study protocol
379377-(Uploaded-26-09-2020-16-13-18)-Study-related document.docx
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Perioperative water and electrolyte balance and water homeostasis regulation in children with acute surgery.
2023
https://dx.doi.org/10.1038/s41390-023-02509-1
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF